v3.26.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Mar. 31, 2025
CURRENT ASSETS    
Cash $ 149,789 $ 365,145
Accounts receivable, net [Note 3] 2,932,899 1,658,772
Inventory [Note 3] 1,341,295 1,555,385
Deposits and other receivables 1,432,501 1,059,990
Total current assets 5,856,484 4,639,292
Deposits and other receivables [Note 12] 109,297 109,297
Long-term accounts receivable 130,847 70,713
Property and equipment [Note 13] 3,646 9,599
Operating right of use assets [Note 12] 346,214 812,053
TOTAL ASSETS 6,446,488 5,640,954
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 8,970,870 7,661,924
Convertible promissory notes and short term loans [Note 5] 11,114,209 9,618,738
Term loans, current [Note 6] 14,680,914 2,400,000
Derivative liabilities [Note 8] 445,893 424,200
Advance from customers 1,531,530
Operating lease obligations, current [Note 12] 397,830 531,286
Total current liabilities 37,141,246 20,636,148
Federally guaranteed loans [Note 7] 870,800 870,800
Term loans [Note 6] 12,271,559
Derivative liabilities [Note 8] 1,396,908 1,478,717
Operating lease obligations 397,830
TOTAL LIABILITIES 39,408,954 35,655,054
Mezzanine Equity    
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of March 31, 2026 and March 31, 2025, respectively, 335 and 385 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively [Note 9] 1,714,476 2,000,290
STOCKHOLDERS’ EQUITY (DEFICIENCY)    
Preferred stock, value 1 1
Common stock, $0.001 par value, 125,000,000 authorized as at March 31, 2026 and March 31, 2025. Issued and outstanding common shares: 28,597,315 and 26,081,295 as at March 31, 2026 and March 31, 2025, respectively, and exchangeable shares of 160,672 outstanding as at March 31, 2026 and March 31, 2025. [Note 9] 28,759 26,243
Shares to be issued 1,005,815 and 324,276 shares of common stock as at March 31, 2026 and March 31, 2025, respectively [Note 9] 284,668 284,244
Additional paid-in-capital 107,621,813 107,123,300
Accumulated other comprehensive loss (41,940) (6,393)
Accumulated deficit (142,570,243) (139,441,785)
Total stockholders’ equity (deficiency) (34,676,942) (32,014,390)
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,446,488 5,640,954
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY (DEFICIENCY)    
Preferred stock, value